About
Pando Bioscience is an AI-driven synthetic biology company that develops an ultra-high-throughput screening platform combined with generative AI to engineer and optimize enzymes for the pharmaceutical industry. Their platform is designed to screen enzymes at much larger scale and lower cost than traditional methods to accelerate enzyme optimization across multiple properties.
Explore Pando Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.